Iovance Biotherapeutics, Inc.

321 articles about Iovance Biotherapeutics, Inc.

• Lion Biotechnologies, Inc. Announces Strategic Hires

  8/31/2015

• Lion Biotechnologies, Inc. Announces Second Quarter 2015 Financial Results

  8/11/2015

• Lion Biotechnologies, Inc. To Join Russell Global Index

  6/24/2015

• Lion Biotechnologies, Inc. Receives Orphan Drug Designation For LN-144 For The Treatment Of Malignant Melanoma

  6/10/2015

• Lion Biotechnologies, Inc. Names Molly Henderson Chief Financial Officer

  6/8/2015

• Lion Biotechnologies, Inc. To Participate In Upcoming Investor Conferences

  5/20/2015

• Lion Biotechnologies, Inc. Announces Pricing Of Secondary Offering Of Shares By Selling Stockholders

  5/1/2015

• Lion Biotechnologies, Inc. Announces Publication Of Data From Clinical Study Of Metastatic Cervical Cancer Patients Treated With HPV-TIL

  4/8/2015

• Lion Biotechnologies, Inc. Announces Positive Data From A TIL-Ipilimumab Combination Study In Melanoma

  3/30/2015

• Lion Biotechnologies, Inc. Announces Closing Of Underwritten Public Offering Of Common Stock And Full Exercise Of The Underwriters' Option To Purchase Additional Shares

  3/3/2015

• Lion Biotechnologies, Inc. To Present At Cowen and Company's 35th Annual Healthcare Conference

  3/2/2015

• Lion Biotechnologies, Inc. Prices Public Offering Of Common Stock

  2/26/2015

• Lion Biotechnologies, Inc. Announces Public Offering Of Common Stock

  2/26/2015

• Lion Biotechnologies, Inc. Announces Its Listing On The Nasdaq Global Market

  2/25/2015

• Lion Biotechnologies, Inc. Appoints Ryan Maynard Director And Chair Of Audit Committee

  2/17/2015

• Lion Biotechnologies, Inc. Obtains Exclusive License From NIH To Develop And Commercialize TIL Therapy In Metastatic Melanoma

  2/10/2015

• Lion Biotechnologies, Inc. Announces Allowance Of IND Application To Begin New Phase 2 Study In Metastatic Melanoma

  2/2/2015

• Lion Biotechnologies, Inc. Amends CRADA With National Cancer Institute To Develop TIL Therapy For Additional Cancer Indications

  1/26/2015

• Lion Biotechnologies, Inc. CSO Laszlo Radvanyi Co-Authors Study In Clinical Cancer Research

  1/12/2015

• Lion Biotechnologies, Inc. To Present At Biotech Showcase

  1/6/2015